| Raymond Costa, LPC | |
|
4122 Route 516, Suite C And D, Matawan, NJ 07747-7022 | |
| (732) 679-4500 | |
| (732) 679-4549 |
| Full Name | Raymond Costa |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 4122 Route 516, Matawan, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093083149 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 37PC00394900 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Raymond Costa, LPC 4122 Route 516, Suite C And D, Matawan, NJ 07747-7022 Ph: (732) 679-4500 | Raymond Costa, LPC 4122 Route 516, Suite C And D, Matawan, NJ 07747-7022 Ph: (732) 679-4500 |
News Archive
The system for hospice admissions for patients with advanced dementia, which is a terminal illness, should be guided by patient and family preference for comfort, not estimated life expectancy, says a new study published in the Nov. 3 Journal of the American Medical Association by the Institute for Aging Research at Hebrew SeniorLife, an affiliate of Harvard Medical School.
Children with chronic health conditions are 88% more likely to suffer physical abuse than healthy children, according to research in the March issue of Acta Paediatrica. They are also 154% more likely to suffer a combination of physical abuse and exposure to intimate partner violence than their healthy school friends.
IsoRay, Inc. announced today that it has successfully shipped the first set of Cesium-131 brachytherapy seeds to a Canadian customer for the purpose of furthering research and development of Cesium-131 in Canada. Cesium-131 is currently approved by Health Canada for the treatment of low-risk prostate cancers and has been cleared by the US FDA for treatment of a wide variety of malignant disease (e.g. prostate, head and neck, brain, breast, lung, eye, etc.).
Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October issue of The Lancet Oncology.
› Verified 4 days ago
Mr. David Alexander Cooper, LSW Counselor Medicare: Medicare Enrolled Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 | |
Kimberly Mackanic, LCSW, LCADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 253 Main St Ste 123, Matawan, NJ 07747 Phone: 732-630-5968 | |
Claire Casey, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 166 Main Strreet, Matawan, NJ 07747 Phone: 732-508-7152 | |
Britney Cantel, Counselor Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 | |
Prof. Loverton Fidel, M.A., M.S., M.B.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 169 Main St Ste 2, Matawan, NJ 07747 Phone: 732-247-6263 | |
Mrs. Erin Dockery, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 166 Main St, Matawan, NJ 07747 Phone: 732-290-9040 |